HbA1c Risk Estimation Device, Method, and Program
Summary
EPO published patent application EP4383274A1 for Nissin Foods Holdings' HbA1c risk estimation device, method, and computer program. The invention relates to estimating glycated hemoglobin (HbA1c) levels for diabetes risk assessment using health measurement data. The patent names Noritaka Ando and Naohisa Shobako as inventors and covers designated states including Germany, France, UK, Italy, Spain, and 23 other European jurisdictions.
What changed
EPO published patent application EP4383274A1 for an HbA1c (glycated hemoglobin) risk estimation device, method, and program developed by Nissin Foods Holdings. The invention estimates HbA1c levels and associated diabetes risk using various health measurement inputs including blood parameters, vital signs, and physiological data. The patent is classified under G16H (Health Informatics) and various A61B (Medical diagnosis) categories.
Affected parties include medical device manufacturers developing blood glucose or diabetes diagnostic products, healthcare technology companies working on metabolic risk assessment tools, and any entities commercializing similar HbA1c estimation technologies in designated EPO member states should conduct freedom-to-operate analyses and consider licensing strategies.
What to do next
- Review patent claims for freedom-to-operate analysis in EU markets
- Monitor EPO register for potential opposition period
- Assess impact on diabetes diagnostic device development programs
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HBA1C RISK ESTIMATION DEVICE, HBA1C RISK ESTIMATION METHOD, AND PROGRAM
Publication EP4383274A1 Kind: A1 Apr 01, 2026
Applicants
NISSIN FOODS HOLDINGS CO., LTD.
Inventors
ANDO, Noritaka, SHOBAKO, Naohisa
IPC Classifications
G16H 50/30 20180101AFI20241220BHEP A61B 5/145 20060101ALI20241220BHEP G16H 40/63 20180101ALI20241220BHEP G16H 50/20 20180101ALI20241220BHEP A61B 5/00 20060101ALI20241220BHEP A61B 5/021 20060101ALN20241220BHEP A61B 5/0245 20060101ALN20241220BHEP A61B 5/1455 20060101ALN20241220BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.